Affordable Access

Access to the full text

Immune Thrombocytopenic Purpura in a Patient With SARS-CoV-2 and Epstein-Barr Virus

Authors
  • Galestanian, Arbi1
  • Suthar, Krishna H1
  • Karnath, Bernard1
  • 1 Internal Medicine, University of Texas Medical Branch, Galveston, USA
Type
Published Article
Journal
Cureus
Publisher
Cureus, Inc.
Publication Date
Feb 28, 2021
Volume
13
Issue
2
Identifiers
DOI: 10.7759/cureus.13615
PMID: 33816014
PMCID: PMC8011470
Source
PubMed Central
Keywords
Disciplines
  • Hematology
License
Green
External links

Abstract

A 35-year-old female was admitted to the hospital for menorrhagia and fatigue. Initial labs revealed that the patient had severe thrombocytopenia and also tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The main objective in this case is to describe the investigation that eventually led to a diagnosis of idiopathic thrombocytopenic purpura (ITP) in the setting of a SARS-CoV-2 coronavirus disease 2019 (COVID-19) infection and co-infection with Epstein-Barr virus (EBV). The majority of ITP cases are idiopathic and most are diagnosed and managed without hospital admission. Admission and careful management were warranted in this particular case. Interestingly, however, the patient did not have any respiratory complications associated with COVID-19. She was given 1 unit of platelets and subsequently received intravenous corticosteroids. Platelet counts improved and the patient was discharged with a course of oral prednisone. This case highlights the importance of understanding the differences between primary and secondary ITP. 

Report this publication

Statistics

Seen <100 times